Translocation renal cell carcinomas (tRCC) are characterized by genetic translocation events involving one member of the (MiT) family, most frequently TFE3 (90% of cases) (Bakouny et al, 2021; Caliò et al, 2019). Here, TFE3 is linked to MIT family translocation renal cell carcinoma.